{"DataElement":{"publicId":"7072165","version":"1","preferredName":"Intravenous Route of Administration Contrast Agent Bolus Infusion Procedure Performed Category","preferredDefinition":"The category of the contrast agent bolus infusion administered intravenously.","longName":"AGCNBLUS","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7071893","version":"1","preferredName":"Procedure Agents Domain Intravenous Route of Administration Contrast Agent Test Dosing Unit Bolus Infusion Procedure Performed","preferredDefinition":"A domain utilized for the submission of information encompassing and representing data, vocabulary or records related to agents used as part of a procedure._Administration within or into a vein or veins._Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue._A dosing unit equal to the amount of active ingredient(s) needed to assess or examine the (potency of the) substance being used._A procedure in which a single dose of a pharmalogical substance is administered, generally via injection, over a short period of time._Executed and carried through to completion.","longName":"6663252v1.0:7071891v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6663252","version":"1","preferredName":"Procedure Agents Domain","preferredDefinition":"A domain utilized for the submission of information encompassing and representing data, vocabulary or records related to agents used as part of a procedure.","longName":"C117755","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Procedure Agents Domain","conceptCode":"C117755","definition":"A domain utilized for the submission of information encompassing and representing data, vocabulary or records related to agents used as part of a procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8394B60A-D64E-39C1-E053-F662850A000B","latestVersionIndicator":"Yes","beginDate":"2019-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-08","modifiedBy":"ONEDATA","dateModified":"2019-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7071891","version":"1","preferredName":"Intravenous Route of Administration Contrast Agent Test Dosing Unit Bolus Infusion Procedure Performed","preferredDefinition":"Administration within or into a vein or veins.:Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.:A dosing unit equal to the amount of active ingredient(s) needed to assess or examine the (potency of the) substance being used.:A single dose of a drug or other substance given over a short period of time. It is usually given by infusion or injection into a blood vessel. It may also be given by mouth.:Executed and carried through to completion.","longName":"7071891v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Route of Administration","conceptCode":"C38276","definition":"Administration of a drug within or into a vein or veins. Introduction of the drug directly into venous circulation results in 100% bioavailability due to an absence of the absorption phase, provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Test Dosing Unit","conceptCode":"C48545","definition":"A dosing unit equal to the amount of active ingredient(s) needed to assess or examine the (potency of the) substance being used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Bolus Infusion Procedure","conceptCode":"C15678","definition":"A procedure in which a single dose of a pharmalogical substance is administered, generally via injection, over a short period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98FD8B2A-6A75-3666-E053-F662850AC59B","latestVersionIndicator":"Yes","beginDate":"2019-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-05","modifiedBy":"ONEDATA","dateModified":"2019-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"98FD8B2A-6A86-3666-E053-F662850AC59B","latestVersionIndicator":"Yes","beginDate":"2019-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-05","modifiedBy":"KUMMEROA","dateModified":"2020-06-11","changeDescription":"Released. AK 2020-6-11 Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3808756","version":"1","preferredName":"Contrast Agent Category","preferredDefinition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue._Category; used informally to mean a class of things.","longName":"3808756v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Biphasic","valueDescription":"Biphasic","ValueMeaning":{"publicId":"3852691","version":"1","preferredName":"Biphasic","longName":"3852691","preferredDefinition":"Occurring in or characterized by two phases or stages.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphasic","conceptCode":"C25435","definition":"Occurring in or characterized by two stages or phases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3BD9C2C-47F1-91DD-E040-BB89AD43312B","latestVersionIndicator":"Yes","beginDate":"2013-08-12","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E3BD9C2C-4809-91DD-E040-BB89AD43312B","beginDate":"2013-07-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-12","modifiedBy":"ONEDATA","dateModified":"2013-08-12","deletedIndicator":"No"},{"value":"Monophasic","valueDescription":"Monophasic","ValueMeaning":{"publicId":"3852692","version":"1","preferredName":"Monophasic","longName":"3852692","preferredDefinition":"Occurring in or characterized by only one phase or stage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monophasic","conceptCode":"C25576","definition":"Occurring in or characterized by only one phase or stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3BD9C2C-4814-91DD-E040-BB89AD43312B","latestVersionIndicator":"Yes","beginDate":"2013-08-12","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E3BD9C2C-482C-91DD-E040-BB89AD43312B","beginDate":"2013-07-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-12","modifiedBy":"ONEDATA","dateModified":"2013-08-12","deletedIndicator":"No"},{"value":"Triphasic","valueDescription":"Triphasic","ValueMeaning":{"publicId":"3852711","version":"1","preferredName":"Triphasic","longName":"3852711","preferredDefinition":"Occurring in or characterized by three phases or stages.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Triphasic","conceptCode":"C107488","definition":"Occurring in or characterized by three phases or stages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3BD9C2C-4862-91DD-E040-BB89AD43312B","latestVersionIndicator":"Yes","beginDate":"2013-08-12","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E3BD9C2C-487A-91DD-E040-BB89AD43312B","beginDate":"2013-07-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-12","modifiedBy":"ONEDATA","dateModified":"2013-08-12","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E09BB972-BF42-70EB-E040-BB89AD430339","beginDate":"2013-07-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-07-03","modifiedBy":"ONEDATA","dateModified":"2013-07-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3808755","version":"1","preferredName":"Contrast Agent Category","preferredDefinition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.:Category; used informally to mean a class of things.","longName":"C390:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E09BB972-BF19-70EB-E040-BB89AD430339","latestVersionIndicator":"Yes","beginDate":"2013-07-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-07-03","modifiedBy":"ONEDATA","dateModified":"2013-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E09BB972-BF2A-70EB-E040-BB89AD430339","latestVersionIndicator":"Yes","beginDate":"2013-07-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-07-03","modifiedBy":"KNABLEJ","dateModified":"2017-07-07","changeDescription":"7/7/17 jk VD released; transferred context and added CSI, registration status per Round 5 finalization task.  8/7/13 added concept for triphasic. jc  7/3/13 created for CT Imaging Agent CRF module. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318324","version":"1","longName":"CT Image - CDISC Aligned ","context":"NCI Standards"},{"publicId":"7318326","version":"1","longName":"CT Image Agent - CDISC Aligned","context":"NCI Standards"}]},{"publicId":"7434158","version":"1","longName":"CTEP CDISC Harmonization","context":"CTEP","ClassificationSchemeItems":[{"publicId":"7590126","version":"1","longName":"CTEP CDISC CT Imaging Agent","context":"CTEP"}]}],"AlternateNames":[{"name":"SUPPAG_QVAL_AGCNBLUS","type":"CTEP CDISC CDE","context":"CTEP"}],"ReferenceDocuments":[{"name":"What type of contrast bolus w","type":"Preferred Question Text","description":"What type of contrast bolus was administered?","url":null,"context":"NCI Standards"},{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 3808775 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"CTEP Text 1","type":"Alternate Question Text","description":"What was the category of the contrast agent bolus administered?","url":null,"context":"CTEP"},{"name":"CTEP Text 2","type":"Alternate Question Text","description":"Category of contract agent bolus administered","url":null,"context":"CTEP"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"990D5214-AC18-0973-E053-F662850A221F","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-06","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Created for CDISC aligned NCI Standard CRF task. ghd","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}